SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim GmbH Release: PRADAX(TM) (Dabigatran Etexilate) Gains Approval in Canada for Stroke Prevention in Atrial Fibrillation